These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 17868650)
1. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells. Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650 [TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions. Taraboletti G; Benelli R; Borsotti P; Rusnati M; Presta M; Giavazzi R; Ruco L; Albini A J Pathol; 1999 May; 188(1):76-81. PubMed ID: 10398144 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology. Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597 [TBL] [Abstract][Full Text] [Related]
4. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein. Hui B; Xia W; Li J; Wang L; Ai J; Geng M J Neurochem; 2006 Apr; 97(2):334-44. PubMed ID: 16539678 [TBL] [Abstract][Full Text] [Related]
5. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion. Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914 [TBL] [Abstract][Full Text] [Related]
6. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein. Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Kaposi's sarcoma in vivo by fenretinide. Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128 [TBL] [Abstract][Full Text] [Related]
8. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload. Hui B; Li J; Geng MY J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356 [TBL] [Abstract][Full Text] [Related]
9. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519 [TBL] [Abstract][Full Text] [Related]
12. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Ensoli B; Barillari G; Salahuddin SZ; Gallo RC; Wong-Staal F Nature; 1990 May; 345(6270):84-6. PubMed ID: 2184372 [TBL] [Abstract][Full Text] [Related]
13. The expression of CD154 by Kaposi's sarcoma cells mediates the anti-apoptotic and migratory effects of HIV-1-TAT protein. Cantaluppi V; Deregibus MC; Biancone L; Deambrosis I; Bussolati B; Albini A; Camussi G Int J Immunopathol Pharmacol; 2006; 19(1):81-96. PubMed ID: 16569346 [TBL] [Abstract][Full Text] [Related]
14. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796 [TBL] [Abstract][Full Text] [Related]
15. Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad. Wu YL; Ai J; Zhao JM; Xiong B; Xin XJ; Geng MY; Xin XL; Jiang HD Acta Pharmacol Sin; 2011 May; 32(5):647-54. PubMed ID: 21499289 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. Samaniego F; Markham PD; Gallo RC; Ensoli B J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237 [TBL] [Abstract][Full Text] [Related]
20. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. Albini A; Fontanini G; Masiello L; Tacchetti C; Bigini D; Luzzi P; Noonan DM; Stetler-Stevenson WG AIDS; 1994 Sep; 8(9):1237-44. PubMed ID: 7528513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]